Faecal calprotectin concentrations in gastrointestinal diseases

Journal of International Medical Research

Volumn 41, Issue 4, 2013, Pages 1357-1361

  Wang, Shaodong ^a   Wang, Zhenkai ^a   Shi, Hui ^a   Heng, Lu ^a   Juan, Wei ^a   Yuan, Boshi ^a   Wu, Xiaochen ^a   Wang, Fangyu ^a  

^a JINLING HOSPITAL   (China)

Author keywords

Calprotectin; gastric inflammation; inflammatory bowel disease; oesophageal inflammation; screening

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CHRONIC GASTRITIS; COLORECTAL POLYP; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DUODENUM ULCER; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGITIS; ESOPHAGUS POLYP; FECES ANALYSIS; FECES LEVEL; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; STOMACH TUMOR; STOMACH ULCER; ULCERATIVE COLITIS;

EID: 84887386791     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513488499     Document Type: Article

References (21)

1. Johne B,Fagerhol MK,Lyberg T,et al.Functional and clinical aspects of the myelomonocyte protein calprotectin.Mol Pathol. 1997;50 (3): 113-123.
2. Schoepfer AM,Beglinger C,Straumann A,et al.Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes.Inflamm Bowel Dis. 2009;15:1851-1858.
3. Angriman I,Scarpa M,D'Incà R,et al.Enzymes in feces: useful markers of chronic inflammatory bowel disease.Clin Chim Acta. 2007;381 (1): 63-68.
4. Vermeire S,Van Assche G,Rutgeerts P.Laboratory markers in IBD: useful, magic, or unnecessary toys?.Gut. 2006;55:426-431.
5. Linskens RK,van Bodegraven AA,Schoorl M,et al.Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis.Dig Dis Sci. 2001;46:644-648.
6. Røseth AG,Fagerhol MK,Aadland E,et al.Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study.Scand J Gastroenterol. 1992;27 (9): 793-738.
7. Fagerhol MK,Dale I,Anderson T.Release and quantitation of a leucocyte derived protein (L1).Scand J Haematol. 1980;24:393-398.
8. Fagerhol MK,Anderson KB,Naess-Andresen CF, et alCalprotectin (the LI leukocyte protein). Stimulus response coupling: the role of intracellular calcium-binding proteins. Boca Raton: CRC Press Inc; 1990:187-210.
9. Dale I,Fagerhol MK,Naesgaard I.Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen.Eur J Biochem. 1983;134:1-6.
10. Wang L,Chang EW,Wong SC,et al.Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins.J Immunol. 2013;190:794-804.
11. Källberg E,Stenström M,Liberg D,et al.CD11b(+)Ly6C(++)Ly6G(-) cells show distinct function in mice with chronic inflammation or tumor burden.BMC Immunol. 2012;13:69-69.
12. Kolho KL,Raivio T,Lindahl H,et al.Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.Scandinavian J Gastro. 2006;41:720-725.
13. Berntzen HB,Fagerhol MK,Ostensen M,et al.The L1 protein as a new indicator of inflammatory activity in patients with juvenile rheumatoid arthritis.J Rheumatol. 1991;18 (1): 133-138.
14. Schoepfer AM,Trummler M,Seeholzer P,et al.Accuracy of four fecal assays in the diagnosis of colitis.Dis Colon Rectum. 2007;50:1697-1706.
15. Carlson CS,Aldred SF,Lee PK,et al.Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels.Am J Hum Genet. 2005;77:64-77.
16. Schoepfer AM,Beglinger C,Straumann A,et al.Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.Am J Gastroenterol. 2010;105 (1): 162-169.
17. Sostegni R,Daperno M,Scaglione N,et al.Review article: Crohn's disease: monitoring disease activity.Aliment Pharmacol Ther. 2003;17:11-7.
18. Bitton A,Peppercorn MA,Antonioli DA,et al.Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis.Gastroenterology. 2001;120:13-20.
19. Schoepfer AM,Trummler M,Seeholzer P,et al.Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies.Inflamm Bowel Dis. 2008;14:32-39.
20. Summerton CB,Longlands MG,Wiener K,et al.Faecal calprotectin: a marker of inflammation throughout the intestinal tract.Eur J Gastroenterol Hepatol. 2002;14 (8): 841-845.
21. Tibble JA,Sigthorsson G,Foster R,et al.Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease.Gastroenterology. 2002;123:450-460.